Multi-omics proteomics analysis — Integrative Proteomics
Multi-Omics Integrative Proteomics Analysis · Also known as: integrative proteomics, multi-omics proteomics integration, proteogenomics multi-omics, cross-omics proteomics
Multi-omics proteomics analysis integrates protein abundance data from mass spectrometry with at least one additional omics layer — such as genomics, transcriptomics, or metabolomics — to build a systems-level view of biological regulation. Rather than analyzing proteins in isolation, this approach correlates proteomic profiles with upstream molecular events (e.g., DNA variants, mRNA levels) and downstream functional readouts (e.g., metabolite concentrations), enabling discovery of regulatory drivers that single-omics analyses would miss.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use multi-omics proteomics analysis when you have paired samples with protein abundance measurements and at least one other omics layer, and your question concerns the regulatory or mechanistic relationship between molecular levels — for example, identifying whether a genomic variant drives a proteomic change, or whether a drug alters protein levels in a way that explains downstream metabolic phenotypes. The method is appropriate for sample sizes of roughly 20 or more per group, as latent-factor and sparse methods require sufficient observations to estimate stable cross-layer correlations. Do not use it when omics layers were not measured on the same samples, when proteomics coverage is very sparse (fewer than ~500 quantified proteins), when you have only one omics layer (use single-omics proteomics analysis instead), or when the research question is a simple differential abundance test rather than a cross-layer integration question.
Strengths & limitations
- Captures regulatory relationships between molecular layers that no single-omics analysis can detect.
- Reduces the multiple-testing burden by focusing on co-varying multi-omics signatures rather than layer-by-layer testing.
- Produces mechanistically interpretable results by linking proteins to upstream genomic or transcriptomic drivers.
- Flexible: applicable to discovery studies (unsupervised MOFA) and supervised classification or biomarker selection (DIABLO).
- Open-source, well-documented frameworks (mixOmics, MOFA+) are available for R and Python.
- Requires high-quality, paired measurements across all omics layers from the same samples — missing layers or poorly matched samples invalidate the integration.
- Demands relatively large sample sizes (typically n ≥ 20 per group) for stable multi-block latent factor estimation.
- Proteomics data typically cover only a fraction of the proteome; low coverage or high missingness can dominate integration artifacts.
- Computational complexity and the need for layer-specific preprocessing expertise make the pipeline technically demanding.
- Causal direction between layers cannot be inferred from correlation-based integration alone; follow-up experimental validation is required.
Frequently asked
What is the difference between MOFA and DIABLO for multi-omics proteomics integration?
MOFA (Multi-Omics Factor Analysis) is an unsupervised method that learns latent factors explaining variance across omics layers without using a response variable — suitable for exploratory analyses and discovery of major sources of biological variation. DIABLO (from the mixOmics package) is a supervised multi-block PLS method that optimises cross-layer correlation subject to discriminating a defined outcome variable (e.g., disease vs. control). Use MOFA when you want to discover structure; use DIABLO when you want to identify a predictive multi-omics signature for a specific phenotype.
How many samples do I need for reliable multi-omics proteomics integration?
As a rule of thumb, aim for at least 20 samples per group (e.g., 20 cases and 20 controls). Sparse integration methods such as DIABLO can be sensitive to overfitting on small datasets; cross-validation with repeated held-out test sets is essential. MOFA is somewhat more robust to smaller samples but still benefits from n ≥ 30 total to estimate stable latent factors.
Can I integrate proteomics with more than two omics layers?
Yes — this is one of the main motivations for multi-omics frameworks. Both MOFA+ and DIABLO support three or more omics blocks simultaneously (e.g., genomics + transcriptomics + proteomics + metabolomics). Adding layers increases interpretability but also raises the risk of overfitting and amplifies the importance of consistent sample pairing and preprocessing across all layers.
Is multi-omics proteomics analysis appropriate for single-cell data?
Single-cell mass spectrometry proteomics (e.g., SCoPE-MS) exists but currently covers far fewer proteins per cell than bulk proteomics. Integration of single-cell proteomics with scRNA-seq is technically feasible using methods like WNN (Seurat v4) or totalVI, but the field is young and the methods are still maturing. For most practical purposes, multi-omics proteomics integration currently applies to bulk or sorted-cell populations.
Do I need to measure all omics layers at the same time point?
For cross-sectional integration (comparing groups), all layers must come from the same samples. For longitudinal studies, temporal matching is also required — mixing time points across layers will produce spurious correlations. If temporal offsets exist (e.g., mRNA precedes protein due to translation lag), dedicated time-lagged correlation methods should be used rather than standard multi-block integration.
Sources
- Rohart, F., Gautier, B., Singh, A., & Le Cao, K.-A. (2017). mixOmics: An R package for omics feature selection and multiple data integration. PLOS Computational Biology, 13(11), e1005752. DOI: 10.1371/journal.pcbi.1005752 ↗
- Singh, A., Shannon, C. P., Gautier, B., Rohart, F., Vacher, M., Tebbutt, S. J., & Le Cao, K.-A. (2019). DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays. Bioinformatics, 35(17), 3055–3062. DOI: 10.1093/bioinformatics/bty1054 ↗
How to cite this page
ScholarGate. (2026, June 3). Multi-Omics Integrative Proteomics Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/multi-omics-proteomics-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Gene Set Enrichment AnalysisBioinformatics↔ compare
- Metabolomics analysisBioinformatics↔ compare
- Multi-omics metabolomics analysisBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare
- Proteomics AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare